Closed call · historical reference
Specific Challenge:Advanced therapies are based on gene, cell or tissue-engineered products which are defined according to the terms of Regulation 1394/2007. So far, only a small number of these products have been placed on the market, and of these, most are for rare diseases. However, in recent ye…
Topics
Partner types
business, research_center, university